ESC Professional Premium Access

Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation

Congress Presentation

About the speaker

Professor Francois Schiele

Regional University Hospital Jean Minjoz, Besancon (France)
16 presentations
1 follower

5 more presentations in this session

LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study

Speaker: Professor A. Maggioni (Florence, IT)

Thumbnail

Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

Speaker: Doctor M. Akhtar (London, GB)

Thumbnail

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

Speaker: Ms J. Schubert (Uppsala, SE)

Thumbnail

Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry

Speaker: Associate Professor M. Leosdottir (Malmo, SE)

Thumbnail

A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

Speaker: Professor K. Ray (London, GB)

Thumbnail

Access the full session

Registries, observational, and other studies on lipids

Speakers: Professor F. Schiele, Professor A. Maggioni, Doctor M. Akhtar, Ms J. Schubert, Associate Professor M. Leosdottir...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations